English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52838375    線上人數 :  785
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c l"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 101-110 / 696 (共70頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2022-03-04T05:33:28Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-03-04T05:33:27Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-02-21T23:31:06Z Measurement of Differential Branching Fractions of Inclusive B →xuℓ+νℓ Decays Cao, L.; Sutcliffe, W.; Van Tonder, R.; Bernlochner, F. U.; Adachi, I.; Aihara, H.; Asner, D. M.; Aushev, T.; Ayad, R.; Babu, V.; Bahinipati, S.; Behera, P.; Belous, K.; Bennett, J.; Bessner, M.; Bilka, T.; Biswal, J.; Bobrov, A.; Bračko, M.; Branchini, P.; Browder, T. E.; Budano, A.; Campajola, M.; Červenkov, D.; Chang, M. C.; Chang, P.; Cheon, B. G.; Chilikin, K.; Cho, H. E.; Cho, K.; Cho, S. J.; Choi, Y.; Choudhury, S.; Cinabro, D.; Cunliffe, S.; Czank, T.; Dash, N.; De Pietro, G.; Dhamija, R.; Di Capua, F.; Dingfelder, J.; DoleŽal, Z.; Dong, T. V.; Dubey, S.; Epifanov, D.; Ferber, T.; Ferlewicz, D.; Frey, A.; Fulsom, B. G.; Garg, R.; Gaur, V.; Gabyshev, N.; Garmash, A.; Giri, A.; Goldenzweig, P.; Gu, T.; Gudkova, K.; Halder, S.; Hara, T.; Hartbrich, O.; Hayasaka, K.; Hernandez Villanueva, M.; Hou, W. S.; Hsu, C. L.; Inami, K.; Ishikawa, A.; Itoh, R.; Iwasaki, M.; Jacobs, W. W.; Jang, E. J.; Jia, S.; Jin, Y.; Joo, K. K.; Kahn, J.; Kang, K. H.; Kichimi, H.; Kiesling, C.; Kim, C. H.; Kim, D. Y.; Kim, S. H.; Kim, Y. K.; Kimmel, T. D.; Kinoshita, K.; Kodyš, P.; Konno, T.; Korobov, A.; Korpar, S.; Kovalenko, E.; KriŽan, P.; Kroeger, R.; Krokovny, P.; Kuhr, T.; Kulasiri, R.; Kumar, M.; Kumar, R.; Kumara, K.; Kuzmin, A.; Kwon, Y. J.; Lee, S. C.; Li, C. H.
臺大學術典藏 2022-02-21T03:52:35Z Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J.
臺大學術典藏 2022-02-21T03:52:33Z Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-02-21T03:52:32Z Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-02-21T03:52:31Z Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J.
臺大學術典藏 2022-02-21T02:04:36Z Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG; Yang M.-H.; Hsu C.
臺大學術典藏 2022-02-21T02:04:35Z Exploring Markers of Exhausted CD8 T Cells to Predict Response to Immune Checkpoint Inhibitor Therapy for Hepatocellular Carcinoma Hsu C.-L.; Ou D.-L.; Bai L.-Y.; Chen C.-W.; Lin L.; Huang S.-F.; ANN-LII CHENG; Jeng Y.-M.; Hsu C.
臺大學術典藏 2022-02-15T06:22:48Z Neuronal Exosomes Secreted under Oxygen–Glucose Deprivation/Reperfusion Presenting Differentially Expressed miRNAs and Affecting Neuronal Survival and Neurite Outgrowth Chiang C.-S.; Fu S.-J.; Hsu C.-L.; Jeng C.-J.; CHIH-YUNG TANG; Huang Y.-S.; Tang S.-C.

顯示項目 101-110 / 696 (共70頁)
<< < 6 7 8 9 10 11 12 13 14 15 > >>
每頁顯示[10|25|50]項目